D. Hernandez

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder

R. Findling, R. Goldman, R. Mankoski, 2015, Journal of autism and developmental disorders.

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder

R. Findling, R. Goldman, R. Mankoski, 2015, Journal of Autism and Developmental Disorders.

A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

R. Tandon, J. Cucchiaro, A. Pikalov, 2016, Journal of psychopharmacology.

Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.

J. McEvoy, L. Citrome, J. Cucchiaro, 2013, The Journal of clinical psychiatry.

EPA-1722 – A Double-blind, Placebo-controlled, Randomized Withdrawal Study of lurasidone for the Maintenance of Efficacy in Patients with Schizophrenia

R. Tandon, J. Cucchiaro, A. Pikalov, 2014, European Psychiatry.

Stellate Ganglion Block Reduces Anxiety Symptoms by Half: A Case Series of 285 Patients

James H Lynch, Sean W. Mulvaney, C. Bryan, 2023, Journal of personalized medicine.